Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00600106 · ClinicalTrials.gov registry record · NA
Data Analyses for Ancillary WISE Femhrt Hormone Replacement Study
A NA study of Myocardial Ischemia, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
- 1
- Study location
NCT00600106 is a NA study of Myocardial Ischemia that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 37 participants, below the 2,137-participant average among 29 other Myocardial Ischemia trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00600106, a NA study of Myocardial Ischemia, has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the main trial was to evaluate the effect of low dose hormone replacement therapy with 1 mg norethindrone/10mcg ethinyl estradiol in postmenopausal women with a history of chest discomfort, myocardial ischemia and no obstructive CAD. For the purposes of this study as a core lab coordinating center, the investigators will be performing P31 MRS core lab analyses; hormone core lab analyses; lipid core lab analyses; glucose, insulin and HOMA core lab analyses; exercise stress test/Holter monitor core lab analyses; brachial artery reactivity test core lab analyses; full study data analyses for manuscript preparation and the writing and submission and publication of manuscript. The main trial duration: December 1999 - May 2003. The ancillary data analysis project duration: April 2006 - March 2010.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG 1/10 NA/EE
Study Locations (1)
California
- Cedars-Sinai Women's Heart Center, 8631 W. 3rd St, Suite 740 - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 1999-12 |
| Est. Completion | 2010-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00600106
The ClinicalTrials.gov registry entry for NCT00600106 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,137-participant average among 29 other Myocardial Ischemia trials with a reported enrollment target (98% lower). The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Myocardial Ischemia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00600106 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00600106 about?
NCT00600106 is a clinical study titled "Data Analyses for Ancillary WISE Femhrt Hormone Replacement Study". The goal of the main trial was to evaluate the effect of low dose hormone replacement therapy with 1 mg norethindrone/10mcg ethinyl estradiol in postmenopausal women with a history of chest discomfort, myocardial ischemia and no obstructive CAD. For the purposes of this study as a core lab coordinat...
What is the current status of trial NCT00600106?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 1999-12. Estimated completion is 2010-03.
What conditions does trial NCT00600106 study?
This clinical trial studies the following conditions: Myocardial Ischemia.
What interventions are being tested in trial NCT00600106?
The interventions under investigation include: Placebo (DRUG), 1/10 NA/EE (DRUG).
Who is sponsoring clinical trial NCT00600106?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00600106 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myocardial Ischemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Bright Light Exposure in Surgical Patients
RECRUITING · NA
-
A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)
RECRUITING · NA
-
Smartphone Twelve-Lead ECG Utility In ST-Elevation Myocardial Infarction II
RECRUITING · NA
-
Secondary Event Prevention Using Population Risk Management After PCI and for Anti-Rheumatic Medications
ACTIVE NOT RECRUITING · NA
-
A Single Center Diagnostic, Cross-sectional Study of Coronary Microvascular Dysfunction
ACTIVE NOT RECRUITING · NA
-
Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.